Common Stock, Shares, Issued of Moleculin Biotech, Inc. from Q4 2015 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Moleculin Biotech, Inc. quarterly Common Stock, Shares, Issued history and change rate from Q4 2015 to Q3 2025.
  • Moleculin Biotech, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2025 was 49.5M shares, a 1549% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Moleculin Biotech, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 49.5M +46.5M +1549% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 30.2M +27.6M +1080% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 14.1M +11.8M +511% Mar 31, 2025 10-Q 2025-05-13
Q4 2024 3.38M +1.15M +51.7% Dec 31, 2024 10-Q 2025-11-13
Q3 2024 3M -26.8M -89.9% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 2.56M -27.2M -91.4% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 2.31M -27.3M -92.2% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 2.23M +319K +16.7% Dec 31, 2023 10-K 2025-03-21
Q3 2023 29.8M +1.18M +4.13% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 29.8M +1.18M +4.13% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 29.6M +1.02M +3.58% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 1.91M -26.7M -93.3% Dec 31, 2022 10-K 2024-03-22
Q3 2022 28.6M +50.7K +0.18% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 28.6M +54.5K +0.19% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 28.6M +134K +0.47% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 28.6M +17M +148% Dec 31, 2021 10-Q 2022-11-10
Q3 2021 28.6M -33.2M -53.7% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 28.6M -31.9M -52.7% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 28.4M -24.8M -46.6% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 11.5M +3.92M +51.4% Dec 31, 2020 10-K 2022-03-24
Q3 2020 61.8M +16M +35.1% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 60.4M +15.2M +33.6% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 53.2M +18.8M +54.7% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 7.62M -20.9M -73.3% Dec 31, 2019 10-K 2021-03-24
Q3 2019 45.7M +18.9M +70.2% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 45.2M +18.3M +68.3% Jun 30, 2019 10-Q 2019-08-16
Q1 2019 34.4M +8.64M +33.5% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 28.5M +7.06M +32.9% Dec 31, 2018 10-K 2020-03-19
Q3 2018 26.9M +6.04M +29% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 26.9M +6.7M +33.2% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 25.8M +8.01M +45.1% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 21.5M +9.3M +76.5% Dec 31, 2017 10-K 2019-02-21
Q3 2017 20.8M +8.77M +72.7% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 20.2M +8.91M +79.2% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 17.8M +11M +162% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 12.2M +5.5M +82.6% Dec 31, 2016 10-K 2018-03-28
Q3 2016 12.1M Sep 30, 2016 10-Q 2016-11-21
Q2 2016 11.3M Jun 30, 2016 10-Q 2016-11-21
Q1 2016 6.79M Mar 31, 2016 10-Q 2016-06-16
Q4 2015 6.66M Dec 31, 2015 10-K 2017-04-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.